Background and aim. Since the market withdrawal of the ASR hip resurfacing in August 2010 because of a higher than expected revision rate as reported in the Australian Joint Replacement Registry (AOAJRR), metal-on-metal hip resurfacing arthroplasty (MoMHRA) has become a controversial procedure for hip replacement. Failures related to destructive adverse local tissue reactions to metal wear debris have further discredited MoMHRA. Longer term series from experienced resurfacing specialists however, demonstrated good outcomes with excellent 10-to-15-year survivorship in young and active men. These results have recently been confirmed for some MoMHRA designs in the AOAJRR. Besides, all hip replacement registries report significantly worse survivorship of total hip arthroplasty (THA) in patients under 50 compared to older ages. The aim of this study was to review MoMHRA survivorship from the national registries reporting on hip resurfacing and determine the risk factors for revision in the different registries. Methods. The latest annual reports from the AOAJRR, the National Joint Registry of England and Wales (NJR), the Swedish Hip Registry (SHR), the Finnish Arthroplasty Registry, the New Zealand Joint Registry and the Arthroplasty Registry of the Emilia-Romagna Region in Italy (RIPO) were reviewed for 10-year survivorship of MoMHRA in general and specific designs in particular. Other registries did not have enough hip resurfacing data or long term data yet. The survivorship data were compared to conventional THA in comparable age groups and determinants for success/failure such as gender, age, diagnosis, implant design and size and surgical experience were reviewed. Results. All registries showed a significant decline of the use of MoMHRA. The AOAJRR reported a cumulative revision rate of 9.5% (95%CI: 8.9–10.1%) at 10 years for all hip resurfacings. Female gender, developmental dysplasia and femoral head sizes <49mm were significant risk factors with revision rates twice as high for head sizes <49mm compared to >55mm. In males, cumulative revision rate for all MoMHRA was 6.6% at 10 years and 7.8% at 13years with no difference in the age groups. ASR had significantly higher revision rates (23.9% at 7 years) compared to other designs. The Adept and the Mitch had the lowest revision rates at 7 years (3.6%). Cumulative revision rates for 10,750 BHR (males and females pooled) were 5.0% at 7 years, 6.9% at 10years and 8.4% at 13 years. Cumulative revision rates of THA in patients <55 years was 6.0% at 10 years and 9.4% at 13 years. Similar survivorship results were found in the Finnish, Swedish, New Zealand and RIPO registry. In the SHR, 10-year survivorship of THA in patients <50 was only around 87%. In the NJR, cumulative revision rates for all MoMHRA pooled were much less favourable (13% at 10 years – 22% in patients<50) but the revision probability of ASR was 30.4% compared to 9.0% for BHR. Surgical experience was also identified as an important determinant of success/failure. Discussion. Registries are now confirming good 10-year survivorship of certain MoMHRA designs with excellent results in males. Risk factors for revision are female gender, small head size, dysplasia and certain implant designs

Introduction. A recent report based on the NARA database (Nordic Arthroplasty Register Association) found that the 10-year survivorship of patients under 50 with traditional total hip arthroplasty was only 83% in 14,600 cases. The purpose of this study was to compare our experience using metal-on-metal hip resurfacing arthroplasty (HRA) to treat these patients. Methods. from May 2001 to Feb 2012, a single surgeon performed 1029 metal-on-metal HRA in 855 patients younger than 50 years old. Three different implants were used in consecutive groups of patients, first the Corin hybrid HRA (182); then the Biomet hybrid HRA (306); and finally the Biomet uncemented HRA (541). The primary diagnoses were OA (707); dysplasia (125); osteonecrosis (98); post-trauma (28); Legg-Calve-Perthes (27) and others (44). The average age was 43±6 years; 74% were men; the average BMI was 27±4; mean femoral component size was 50±4 (range 40–62); the average T-score was 0±1. 37% of our patients reported a UCLA Activity level of 9 or 10 (impact sports). Six died with causes unrelated to their HRAs. The rate of follow-up was 94%. Our patients were not selected by any criteria except the surgeon's technical ability to perform an HRA. Results. There were a total 42 failures: acetabular component loosening in 15 cases (8 before two years) femoral component loosening in 9 cases; femoral neck fracture in 5 cases; adverse wear related failure (AWRF) in 4 cases; deep infection in 3 cases; recurrent dislocation in 1 case; other causes in 5 cases. With revision of any component as the end point, the Kaplan-Meier survivorship rate was 94.9% at 8 years and 92.5% at 10 years for the entire group. We compared survivorship between groups at shorter follow-up intervals to determine if results were improving. The survivorship rate at 8 years for Biomet Hybrid group was 95.8%, which was significantly better than 89.1% for the earlier Corin Hybrid group; the survivorship rate at 5 years for the latest Biomet Uncemented HRA group was 98.7%, also better than 96.5% for the prior Biomet Hybrid group. (P=0.0001). Conclusion. Metal-on-metal hip resurfacing has less than half the 10-year failure rate of THR in young patients. As HRA technology and experience improve, our data suggests that the results further improve. HRA currently meets the NICE criteria for 10-year survivorship of implants while THR doesn't in young patients. Our HRA patients are allowed unrestricted activity, while THR patients are typically restricted. AWRF (0.4%) is a minor problem that has been blown far out of proportion to its significance. Patient selection against HRA in certain subgroups (women, small bearings, history of metal allergy) may not be advisable based on our results

Tapered fluted grit-blasted modular stems have now become established as a successful method of femoral revision. The success of these stems is predicated on obtaining axial stability by milling the femur to a cone and then inserting the tapered prosthesis into that cone. Torsional stability is gained by flutes that cut into the diaphysis. By having modular proximal segments of different lengths, the leg length, offset, and anteversion can be adjusted after the distal stem is fixed. This maximises the chance for the stem to be driven into the canal to whatever level provides maximum stem stability. Modular fluted tapered stems have the potential benefits of being made of titanium and hence being both bone friendly and also having a modulus of elasticity closer to that of bone. They have a well-established high rate of fixation. Drawbacks include the risk of fracture of modular junctions and tapers, and difficulty of extraction. The indications for the use of these implants vary among surgeons, but the implants are suitable for use in a wide variety of bone loss categories. Non-modular fluted tapered stems also can gain excellent fixation, but are less versatile and in most practices are used for selected simpler revisions. Results from a number of institutions in North America and Europe demonstrate high rates of implant fixation. In a recently published paper from Mayo Clinic, the 10-year survivorship, free of femoral aseptic loosening revision, of a modular fluted tapered stem was 98% and the stem performed well across a wide range of bone deficiencies. The technique of implantation will be described in a video during the presentation

In revision total hip arthroplasty (THA), acetabular reconstruction while dealing with severe bone loss is a challenge. The porous tantalum revision acetabular shells have been in use for the past decade. Several reports have documented successful use at early to mid-term follow up. There is, however, very little literature around the long-term survival and quality of life outcome with the use of these shells. We reviewed the results of 46 acetabular revisions with Paprosky 2 and 3 acetabular bone defects reconstructed with a hemispheric, tantalum acetabular shell and multiple supplementary screws. There were 31 females. Average age at revision was 64 years (range 23–85 years). The mean and median follow up was 11 years (range 10–12 years, SD 1). Morselised femoral allograft was used in 34 hips to fill contained cavitary defectes. Bulk femoral allografting was performed in 2 hips. At a minimum follow-up of 10 (range 10–12) years, the survivorship of the porous tantalum acetabular shell, with revision of the shell as end point was 96%. The minimum 10-year survivorship with hip revision for any reason as end point was 92%. We noted excellent pain relief (mean WOMAC pain 92.6) and good functional outcome (mean WOMAC function 90.3, mean UCLA 5); and generic quality of life measures (mean SF-12 physical component 48.3; mean SF-12 mental component 56.7). Patient satisfaction with pain relief, function and return to recreational activities were noted to be excellent. Cementless acetabular revision with the tantalum acetabular shell demonstrated excellent clinical and quality of life outcomes at minimum 10-year follow-up. As far as we are aware this is the first report of minimum 10-year follow up of use of this technique for revision hip arthroplasty

Introduction. We sought to determine the 10-year survivorship of single-radius, posterior-stabilized total knee arthroplasty (TKA) in Asian patients. We also aimed to determine whether the long-term clinical and radiographic results differed between patients with and without patellar resurfacing. Materials and Methods. This retrospective study included 148 (115 patients) consecutive single-radius, posterior-stabilized TKAs. Ten-year survivorship analysis was performed using the Kaplan-Meier method with additional surgery for any reason as the end-point. Furthermore, long-term clinical and radiographic results of 109 knees (74%; 84 patients) with more than a 10-year follow-up were analyzed. Ten-year survivorship and long-term outcomes after surgery were determined, and outcomes were compared between patients with and without patellar resurfacing. Results. Cumulative survival rate of the single-radius posterior-stabilized TKA of 148 knees was 97.7% (95% confidence interval, 93.1%–99.3%) at 10 years after surgery. Three knees had additional surgery during the 10-year follow-up because of one case of instability and two periprosthetic infections. Mean postoperative Knee Society knee score and function score were 97 and 75, respectively. There was no aseptic loosening of the prosthesis, even though a non-progressive radiolucent line was found in 10 (9%) knees. There were no differences in postoperative scores and degree of patellar tilt and displacement between patients with and without patellar resurfacing. Conclusions. Single-radius, posterior-stabilized TKA showed satisfactory long-term clinical and radiographic outcomes in Asian patients regardless of patellar resurfacing, with comparable survivorship to that reported in westerners

Introduction & Objective. Labral refixation has established as a standard in open or arthroscopic treatment for femoroacetabular impingement (FAI). The rationale for this refixation is to maintain the important suction seal in the hip. To date, only few short-term results are available which indicate a superior result in FAI hips with labral refixation compared to labral resection. Scientific evidence of a beneficial effect of labral refixation in the long-term follow-up is lacking. Aim of this study was to evaluate if labral refixation can improve the cumulative 10-year survivorship in hips undergoing surgical hip dislocation for FAI compared to labral resection. Methods. We performed a retrospective comparative study of 59 patients treated with surgical hip dislocation for symptomatic FAI between December 1998 and January 2003. We analyzed two matched groups: The ‘resection’ group consisted of 25 hips that were treated consistently by excision of the damaged labrum. The ‘refixation’ group consisted of 34 hips that were treated with labral reattachment. Correction of the osseous deformity (rim trimming/femoral osteochondroplasty) did not differ between the two groups. We then evaluated the clinical (Merle d'Aubigné score) and radiographical results (according to Tönnis) at a follow-up of ten years. We calculated a cumulative Kaplan-Meier survivorship curve with the following factors as endpoints: conversion to total hip arthroplasty (THA), radiographic evidence of osteoarthritis progression, or a poor clinical result (defined as Merle d'Aubigné score of less than 15). The two curves were compared using the Log-rank test. Results. Hips with labral refixation had a significantly higher survivorship (78%, 95% confidence interval [CI] 64–92%) at ten years compared to labral resection (46%, 95% CI 26–66, p=0.008). 7 (20.6%) patients in the refixation group reached an endpoint: 2 with THA; 5 with a poor clinical result, and 5 with progression of OA. 15 (60.0%) patients in the resection group reached an endpoint: 3 with THA; 12 with a poor clinical result, and 4 with progression of OA. Conclusion. This is the first study proving that labral refixation leads to significantly better results in patients 10 years after open surgical hip dislocation for FAI. It seems advisable to preserve the labrum in this patient population whenever possible

We set out to demonstrate the 10-year survivorship of the PFC sigma TKA in a young patient group. Demographic and clinical outcome data were collected prospectively at 6 months, 18 months, 3 years, 5 years and 8–10 years post surgery. The data were analysed using Kaplan Meier survival statistics with end point being regarded as death or revision for any reason. 203 patients were found to be < 55 years at the time of surgery. Four patients required revision and four patients died. Another four patients moved away from the region and were excluded from the study. A total of 224 knees in 199 patients (101 male and 98 females.) 168 patients had a diagnosis of Osteoarthritis and 28 with inflammatory arthritis. Average age 50.6 years range 28–55 years (median 51). Ten-year survivorship in terms of revision 98.2% at ten years 95% confidence interval. Our results demonstrate that the PFC Sigma knee has an excellent survival rate in young patients over the first 10 years. TKR should not be withheld from patients on the basis of age

Introduction:. Hard-on-hard bearings and surface replacement (SR) have been used in young and active patients due to the reduced wear and lower rates of osteolysis. However, neither of these options resulted in survivorship higher than 90%–95% in this group of patients. The purpose of this prospective study was to compare minimum 10-year survivorship of non-cemented total hip arthroplasty (THA) using 28 mm metal head against highly-cross linked polyethylene (HXLPE) in our cohort as compared to published reports of other bearings, including surface replacements, in young-active patients. Matierial and Methods:. From 1999 to 2003, 91 consecutive patients (112 hips; 57 males and 34 females) with average UCLA score of 8 and mean age 53 years (range 24–65 years), who received metal on HXLP (Crossfire), were included. At minimum 10-years follow-up, patients' clinical data was assessed. All level I, II studies, registry data, and prospective cohorts published in the literature with minimum 10 years of surface replacement (SR) and ceramic on ceramic (CoC) in young patients were included. Results:. There were no revisions for fracture, osteolysis or loosening. There were 2 revisions: one periprosthetic infection and one chronic dislocation. Kaplan-Meier survivorship was 97% for all cause failures and 100% for wear-related failures. In review of the literature, the 10-year results of metal on HCLPE in young patients as well as the registry data were similar or better than SR and CoC. Discussion and Conclusion:. This study demonstrates that 28 mm metal head on HXLPE has lower revision rates as compared to other bearings and surface replacement in the published literature at a minimum 10-year follow-up in young-active patients, without the limitations of heard-on-heard bearings. This bearing should be considered as the gold standard for young and middle age patients. Oxidation of Crossfire is an overly stated limitation

INTRODUCTION. The literature suggests a survivorship of unicompartmental knee arthroplasties (UKA) for spontaneous osteonecrosisof the knee range from 93% to 96.7% at 10 to 12 years. However, these data arise from series reporting 23 to 33 patients, jeopardizing meaningful conclusions. OBJECTIVES. Our purpose is to examine a long term survivorship of UKA's in a larger group of patients with SPONK, along with their subjective, symptomatic and functional outcome; to determine the percentage of failures and the reasons for the same in an attempt to identify relevant indications, contraindications, and technical parameters in treating SPONK with a modern implant design. METHODS. We retrospectively evaluated 84 patients with late-stage spontaneous osteonecrosis of the knee who had a medial UKA from 1998 to 2005. All patients had preoperative MRI to confirm the diagnosis, exclude metaphyseal involvemente, and confirm the absence of major degenerative changes in the lateral and patellofermoal compartment. Mean age at surgery was 66 years and mean body mass index was 28.9. A Kaplan-Meier survival analysis was conducted using revision for any reason as the end point. The minimum followup of 63 months (mean, 98 months; range, 63–145 months). RESULTS. The 10-year survivorship was 92%. Ten revisons were performed and the most common reasons for revision were subsidence of the tibial component (four) and aseptic loosening of the tibial component (three). No patient underwent revision for osteoarthritis progression in the lateral or patellofemoral compartment. There was a statistically significant difference between postoperative VAS, KSS, WOMAC, Oxford, Range of Motion and Tibial Slope (overcorrected by 3.7 degrees, p< 0.0023) between the survivors and the failures. CONCLUSION. SPONK may be an optimal indication for UKA provided secondary osteonecrosis of the knee is ruled out; pre-operative MRI is performed to document involvement of other compartments, status of the ligaments and depth of lesion; and there is no over-correction in any plane

Background and aim. Arthroplasty registries and consecutive series indicate significantly worse results of conventional metal-on-polyethylene total hip arthroplasty (THA) in patients younger than 50 years compared to older patients, with inferior clinical outcomes and 10-year survivorship ranging between 70 and 90%. At our institution, patients under 50 needing a THA receive either a metal-on-metal hip resurfacing (MoMHRA) or a ceramic-on-ceramic (CoC)THA. In order to evaluate the outcome of these options at minimum 10 years, we conducted a retrospective review of all MoMHRA and CoCTHA with more than 10 years follow-up implanted in patients under 50. Methods. From a single surgeon patients’ prospective database, we identified all consecutive THA performed before May 2005 in patients under 50. All patients are contacted by phone and asked to present for a clinical exam and patient reported outcome questionnaires, standard radiographs and metal ion measurements unless the hip arthroplasty has been revised. Complications and reasons for revision are noted. Kaplan-Meier survivorship is analysed for the whole cohort and sub-analysis is performed by type hip arthroplasty, gender, diagnosis and component size. Results. We identified 773 hip arthroplasties in 684 patients under 50 years performed by a single surgeon between 1997 and May 2005. There are 626 MoMHRA, all Birmingham Hip Resurfacings (BHR) in 561 patients (65 bilateral BHR), 135 CoCTHA in 111 patients (24 bilateral CoC) and 12 Metasul MoMTHA in 12 patients. In the BHR group, there are 392 males (70%) (42 bilateral) and 169 females (30%) (23 bilateral). Mean age at surgery was 40.8 years (median 42 years; range 16–50 years). In 33 cases, a BHR dysplasia cup was used (23 in females). Mean follow-up is 11.5 years (median 11 years; range 10–17 years). In the Metasul MoMTHA, there are 8 males and 4 females. Mean age at surgery was 40.4 years (range 20–50 years). All THA were non-cemented and head size was 28mm in all cases. Mean follow-up is 16.8 years (median 17.5 years; range 12–19 years). In the CoCTHA group, there are 71 males (64%) (17 bilateral) and 40 females (36%) (7 bilateral). Mean age at surgery was 38.2 years (median 39 years; range 16–50 years). In 21 cases, the CoCTHA was a revision of a former hip replacement: 15 THA revisions and 6 hip resurfacing revisions. Three types non-cemented acetabular components were used and 7 types femoral stems (5 non-cemented; 2 cemented). Ceramic heads and inlays were Biolox forte in 128 cases and Biolox delta in 7. Head size was 28mm in 125, 32mm in 7 and 36mm in 3. Mean follow-up is 14.9 years (median 15 years; range 10–18 years). Discussion. Patients under 50 needing a hip arthroplasty often present with more complex anatomic abnormalities or bone damage as in congenital dysplasia, avascular necrosis, traumatic osteoarthritis or rheumatic diseases. Besides, the worse results with conventional THA in young patients may be related to a higher activity level. We present the outcome and survivorship of MoMHRA and CoCTHA in patients under 50 at more than 10 years postop

Introduction:. One reason that young and active patients choose hip resurfacing arthroplasty (HRA) rather than stemmed total hip arthroplasty (THA) is that they wish to return to high impact sports after their operation. Few studies have addressed the outcome in hip arthroplasty patients who choose to participate in high impact sports post-operatively. We therefore wanted to determine if the durability of HRA in highly active patients was decreased. Methods:. From 5/2001 to 5/2011, a single surgeon performed 2434 HRA cases in 2013 patients. The study group consists of all patients that had a UCLA Activity score of 9 or 10 at any point after surgery in our prospective database. There were 936 (38%) cases in 776 patients who reported participating in high impact sports at some point after surgery. This group was compared to the entire database. The mean age of the study group was 50 ± 8 years, which was significantly younger than the entire group (P = 0.0007). 82% of the study group was male compared to 73% in the entire group (P < 0.0001). 85% of the primary diagnoses were osteoarthritis in the study group compared to 78% in the entire group (P < 0.0001), followed by dysplasia (8%) and osteonecrosis (4%). Results:. For the study group, the average follow-up length was 4 ± 2 years. 389 (42%) cases had at least 5 years follow-up. 10 (1%) revisions were identified: five (0.5%) due to femoral component loosening; two (0.2%) due to adverse wear; two (0.2%) for acetabular component loosening; one (0.1%) for acetabular fracture. There was no difference in the failure rate due to any specific complication type. The Kaplan-Meier survivorship rate was 99.5% at 5 years and 95.8% at 10 years, which compared to 96.9% at 5 years and 91.6 at 10 years for the entire group. 61 cases had the acetabular inclination angles >50°; 2 of which were revised for adverse wear related failures. Metal ion test results were available for 52% cases in the study group. Metal ion levels were ≥7 μg/L in 18 (1.9%) cases and ≥10 μg/L in 11 (1.2%). Excluding the failed cases, the average Harris hip scores were 99 ± 3 for the study group which was significantly better than the entire group (P < 0.0001). Discussion:. When compared to the entire database, hip resurfacing patients that participate in high impact sports after surgery have a significantly higher HHS; they have a similar 10-year survivorship of 95.8%; they have a similar low adverse wear failure rate of 0.2%. We therefore conclude that a patient's activity level has little effect on the 10 year outcome of HRA and that restrictions are therefore not necessary after hip resurfacing

Introduction. Metal-on-metal hip resurfacings (MoMHRAs) have a characteristic wear pattern initially characterised by a run-in period, followed by a lower-wear steady-state. The use of metal ions as surrogate markers of in-vivo wear is now recommended as a screening tool for the in-vivo performance of MoMHRAs. The aims of this retrospective study were to measure ion levels in MoMHRAs at different stages during the steady-state in order to study the evolution of wear at minimum 10 years postoperatively and describe factors that affect it. Materials and methods. A retrospective study was conducted to investigate the minimum 10-year survivorship of a single-surgeon Birmingham Hip Resurfacing (BHR) series, and the evolution of metal ion levels. Implant survival, Harris Hip Scores (HHS), radiographs and serum metal ion levels were assessed. The evolution of metal ion levels was evaluated in 80 patients for whom at least two ion measurements were available at more than 12 months postoperatively, i.e. past the run-in phase. Ion level change (Delta Cr; Delta Co) was defined as Cr or Co level at last assessment minus Cr or Co level at initial assessment. Sub-analysis was performed by gender, diagnosis, age, femoral component size and cup inclination angle. Results. Overall Cr and Co levels were low (Cr: 1.3 μg/L; Co: 1.0 μg/L for unilateral and Cr: 3.2 μg/L; Co: 2.3 μg/L for bilateral resurfacings) and decreased significantly (p < 0.001) from the initial assessment at 4 to 8 years postoperatively (median 6 years) to the last assessment at 10 to 13 years (median 11 years) with a mean reduction of 1.24 μg/L for Cr (Median: −0.80; SD: 1.948; Range: −11.8 to +2.0 μg/L) (p < 0.001) and 0.88 μg/L for Co (Median: −0.75; SD: 1.645; Range: −7.5 to +5.3 μg/L) (p < 0.001). Three patients (4%) had an increase of Co ions >2.5 μg/L, associated with head sizes £50 mm and with clinical symptoms and high cup inclination angles. There was no significant difference in the change of ion levels between genders (Cr: p = 0.845; Co: p = 0.310) although Cr levels at initial and last assessments were higher in females (p = 0.008). Component size did not correlate with change in ion levels (Cr: p = 0.505; Co: p = 0.370). Patients with increased ion levels at follow-up had lower Harris Hip Scores (p = 0.038). Discussion. Low serum Cr and Co ion levels were found in patients with well-functioning unilateral and bilateral MoMHRA. In well-functioning MoMHRA ion levels continue to be low even after . 3. 10 years in situ. In this series, there were no symptomatic patients with low metal ion levels. Increasing metal ion levels >10 μg/l were invariably associated with poorly functioning MoMHRA. The analysis of consecutive ion levels demonstrated a statistically significant overall decrease of Cr and Co levels with time in well-functioning BHR. In 25% of patients ion levels were undetectable at . 3. 10 years postoperatively. Our data are in accordance with tribocorrosion studies indicating a lower-wear bedding-in phase after the initial running-in phase of higher wear. An increase in ion levels after the run-in phase is an indication of continued surface wear which may eventually lead to implant failure potentially associated with soft tissue and bone destruction

Debridement, antibiotics and implant retention (DAIR) is a surgical option in the treatment of prosthetic joint infection (PJI). It is thought to be most appropriate in the treatment of early (≤6 weeks post-op) PJI. Most studies to-date reporting on DAIRs in hip PJI have been underpowered by reporting on small cohorts (n= <45), or report on registry data with associated biases and limitations. In our, tertiary referral, bone infection unit we consider DAIR to be a suitable option in all cases of PJI with a soundly fixed prosthesis, with early or late presentation, especially in patients who are too elderly or infirm to undergo major surgery. Aim: To define the 10-year outcome following DAIR in hip PJI and identify factors that influence it. We retrospectively reviewed all DAIRs performed in our unit between 1997 and 2013 for hip PJI. Only infected cases confirmed by histological and microbiological criteria were included. Data recorded included patient demographics and medical history, type of surgery performed (DAIR or DAIR + exchange of modular components), organism identified and type/duration of antibiotic treatment. Outcome measures included complications, mortality rate, implant survivorship and functional outcome. 121 DAIRs were identified with mean age of 71 years (range: 33–97). 67% followed an index procedure of 1° arthroplasty. 53% included exchange of modular components. 60% of DAIRs were for early onset PJI. Isolated staphylococcus was present in 50% of cases and 25% had polymicrobial infection. At follow-up (mean:7 years, range: 0.3 – 18), 83 patients were alive; 5- and 10- year mortality rates were 15% and 35% respectively. 45% had a complication (persistence of infection: 27%, dislocation: 10%) and 40% required further surgery. Twenty hips have been revised to-date (17%). Performing a DAIR and not exchanging the modular components was associated with an almost 3× risk (risk ratio: 2.9) of subsequent implant failure (p=0.04). 10-yr implant survivorship was 80% (95%CI: 70 – 90%). Improved 10-year implant survivorship was associated with DAIR performed for early PJI (85% Vs 68%, p=0.04). Functional outcome will be discussed. DAIR is a particularly valuable option in the treatment of hip PJI, especially in the early post-operative period. Whenever possible, exchange of modular implants should be undertaken, however DAIRs are associated with increased morbidity even in early PJI. Factors that predict success of DAIR in late PJI need to be identified

Background. Cross-linked polyethylene has much less wear than conventional polyethylene and can used in a more bone conserving thickness of 4 mm. We have used it for hip resurfacing since 2001. Questions/Purposes. This study evaluated the effectiveness of a highly cross-linked polyethylene acetabular component for hip resurfacing in patients under age 50. I posed 5 questions: (1) What are the functional results, (2) What are the complications, (3) What is the 10-year implant survivorship, (4) What is the femoral head penetration into the polyethylene, and (5) What is the bone conservation?. Participants and Methods. There were 160 resurfacing procedures (144 participants) using a 2 piece acetabular shell and a cobalt chromium femoral component (fig. 1). Participants averaged 43 years of age at the time of surgery (range, 23 – 49.5 years) and 70% were women. Inclusion criteria were patients with adequate acetabular bone and a high enough head-neck ratio so that the reconstruction would not violate the femoral neck cortices or medial acetabular wall. The largest cross-linked polyethylene available was 49 mm so only patients with smaller femoral geometries were included. The Harris, WOMAC, and UCLA hip scores were used to assess pain, activity, and function and participants were asked about their satisfaction with the procedure. Digital radiography and computed tomographic scans were used to evaluate femoral head penetration and osteolysis. Removed polyethylene liners were analyzed. Results. The median follow-up was 11.5 years (range, 10 – 14 years). One participant was lost to follow-up and 1 died. The mean Harris Hip Score was 95 and 95% of the participants rated the results of their procedure as excellent. The average UCLA activity score was 8. One patient underwent successful revision surgery for acetabular loosening. Four participants underwent successful revision to a total hip replacement because of femoral neck fracture (2), femoral loosening, or infection. The Kaplan-Meier survivorship was 96%. There were no revisions for polyethylene wear and there were no instances of osteolysis. The medial acetabular wall thickness averaged 7.3 mm (range, 1.5 mm – 14.9 mm). The mean inclination angle was 39°. The mean femoral head penetration was 0.05 mm/year (range, .028 – .09 mm/year). Conclusions. Hip resurfacing with a highly cross-linked polyethylene acetabular component is a reliable procedure at mid-term follow-up. The rate of polyethylene wear is below the osteolytic threshold of .1 mm/yr. The preservation of both acetabular and femoral bone is reasonable even in comparison to thin metal shells available for metal-on-metal resurfacing and total hip replacement. The functional results are comparable to those of metal-on-metal resurfacing without the concerns of a metal bearing couple. The procedures are demanding and patient selection is critical to the success of the procedure. Although long-term follow-up is needed to determine if implant survivorship with highly cross-linked polyethylene acetabular components will equal that of metal-on-metal prostheses, the low rate of femoral head penetration suggests that many years of use in young highly active participants are possible